Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Angiogenic and Arthritogenic Properties of the Soluble Form of CD13.

Du Y, Lu C, Morgan RL, Stinson WA, Campbell PL, Cealey E, Fu W, Lepore NJ, Hervoso JL, Cui H, Urquhart AG, Lawton JN, Chung KC, Fox DA, Amin MA.

J Immunol. 2019 Jul 15;203(2):360-369. doi: 10.4049/jimmunol.1801276. Epub 2019 Jun 12.

PMID:
31189572
2.

Defining ranges for certainty ratings of diagnostic accuracy: a GRADE concept paper.

Hultcrantz M, Mustafa RA, Leeflang MMG, Lavergne V, Estrada-Orozco K, Ansari MT, Izcovich A, Singh J, Chong LY, Rutjes A, Steingart K, Stein A, Sekercioglu N, Arevalo-Rodriguez I, Morgan RL, Guyatt G, Bossuyt P, Langendam MW, Schünemann HJ.

J Clin Epidemiol. 2019 May 18. pii: S0895-4356(18)31069-2. doi: 10.1016/j.jclinepi.2019.05.002. [Epub ahead of print]

3.

Imaging at diagnosis impacts cancer-specific survival among patients with cancer of the oropharynx.

Morgan RL, Eguchi MM, Mueller AC, Daugherty SL, Amini A, Karam SD.

Cancer. 2019 May 1. doi: 10.1002/cncr.32148. [Epub ahead of print]

PMID:
31042320
4.

GRADE guidelines for environmental and occupational health: A new series of articles in Environment International.

Morgan RL, Beverly B, Ghersi D, Schünemann HJ, Rooney AA, Whaley P, Zhu YG, Thayer KA; GRADE Working Group.

Environ Int. 2019 Jul;128:11-12. doi: 10.1016/j.envint.2019.04.016. Epub 2019 Apr 24. No abstract available.

5.

Prediction Models for Suicide Attempts and Deaths: A Systematic Review and Simulation.

Belsher BE, Smolenski DJ, Pruitt LD, Bush NE, Beech EH, Workman DE, Morgan RL, Evatt DP, Tucker J, Skopp NA.

JAMA Psychiatry. 2019 Mar 13. doi: 10.1001/jamapsychiatry.2019.0174. [Epub ahead of print]

PMID:
30865249
6.

Detection of oligoprogressive disease in oncogene-addicted non-small cell lung cancer using PET/CT versus CT in patients receiving a tyrosine kinase inhibitor.

Ng TL, Morgan RL, Patil T, Barón AE, Smith DE, Ross Camidge D.

Lung Cancer. 2018 Dec;126:112-118. doi: 10.1016/j.lungcan.2018.10.023. Epub 2018 Oct 23.

PMID:
30527174
7.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.

Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N.

Blood Adv. 2018 Nov 27;2(22):3360-3392. doi: 10.1182/bloodadvances.2018024489. Review.

8.

A risk of bias instrument for non-randomized studies of exposures: A users' guide to its application in the context of GRADE.

Morgan RL, Thayer KA, Santesso N, Holloway AC, Blain R, Eftim SE, Goldstone AE, Ross P, Ansari M, Akl EA, Filippini T, Hansell A, Meerpohl JJ, Mustafa RA, Verbeek J, Vinceti M, Whaley P, Schünemann HJ; GRADE Working Group.

Environ Int. 2019 Jan;122:168-184. doi: 10.1016/j.envint.2018.11.004. Epub 2018 Nov 22.

9.

Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a Network Meta-analysis of Randomized Trials.

Sadeghirad B, Florez ID, Chang Y, Forutan F, Zeraatkar D, Morgan RL, Shahid S, Bala MM, Beyene J, Offringa M, Adams-Webber T, Sherman PM, El-Gouhary E, Guyatt GH, Johnston BC.

Int J Prev Med. 2018 Sep 17;9:83. doi: 10.4103/ijpvm.IJPVM_328_17. eCollection 2018.

10.

Identifying the PECO: A framework for formulating good questions to explore the association of environmental and other exposures with health outcomes.

Morgan RL, Whaley P, Thayer KA, Schünemann HJ.

Environ Int. 2018 Dec;121(Pt 1):1027-1031. doi: 10.1016/j.envint.2018.07.015. Epub 2018 Aug 27. No abstract available.

11.

Evaluation of the risk of bias in non-randomized studies of interventions (ROBINS-I) and the 'target experiment' concept in studies of exposures: Rationale and preliminary instrument development.

Morgan RL, Thayer KA, Santesso N, Holloway AC, Blain R, Eftim SE, Goldstone AE, Ross P, Guyatt G, Schünemann HJ.

Environ Int. 2018 Nov;120:382-387. doi: 10.1016/j.envint.2018.08.018. Epub 2018 Aug 17.

PMID:
30125855
12.

Development of rapid guidelines: 1. Systematic survey of current practices and methods.

Kowalski SC, Morgan RL, Falavigna M, Florez ID, Etxeandia-Ikobaltzeta I, Wiercioch W, Zhang Y, Sakhia F, Ivanova L, Santesso N, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):61. doi: 10.1186/s12961-018-0327-8.

13.

Development of rapid guidelines: 2. A qualitative study with WHO guideline developers.

Florez ID, Morgan RL, Falavigna M, Kowalski SC, Zhang Y, Etxeandia-Ikobaltzeta I, Santesso N, Wiercioch W, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):62. doi: 10.1186/s12961-018-0329-6.

14.

Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations.

Morgan RL, Florez I, Falavigna M, Kowalski S, Akl EA, Thayer KA, Rooney A, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):63. doi: 10.1186/s12961-018-0330-0.

15.

A systematic review of how patients value COPD outcomes.

Zhang Y, Morgan RL, Alonso-Coello P, Wiercioch W, Bała MM, Jaeschke RR, Styczeń K, Pardo-Hernandez H, Selva A, Ara Begum H, Morgano GP, Waligóra M, Agarwal A, Ventresca M, Strzebońska K, Wasylewski MT, Blanco-Silvente L, Kerth JL, Wang M, Zhang Y, Narsingam S, Fei Y, Guyatt G, Schünemann HJ.

Eur Respir J. 2018 Jul 19;52(1). pii: 1800222. doi: 10.1183/13993003.00222-2018. Print 2018 Jul.

PMID:
30002103
16.

Human and Bovine Colostrum for Prevention of Necrotizing Enterocolitis: A Meta-analysis.

Sadeghirad B, Morgan RL, Zeraatkar D, Zea AM, Couban R, Johnston BC, Florez ID.

Pediatrics. 2018 Aug;142(2). pii: e20180767. doi: 10.1542/peds.2018-0767. Epub 2018 Jul 10.

PMID:
29991526
17.

Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment.

Dobler CC, Morgan RL, Falck-Ytter Y, Montori VM, Murad MH.

BMJ Evid Based Med. 2018 Apr;23(2):50-53. doi: 10.1136/bmjebm-2017-110852. Epub 2018 Feb 26.

PMID:
29595129
18.

A scoping review and survey provides the rationale, perceptions, and preferences for the integration of randomized and nonrandomized studies in evidence syntheses and GRADE assessments.

Cuello-Garcia CA, Morgan RL, Brozek J, Santesso N, Verbeek J, Thayer K, Guyatt G, Schünemann HJ.

J Clin Epidemiol. 2018 Jun;98:33-40. doi: 10.1016/j.jclinepi.2018.01.010. Epub 2018 Feb 13. Review.

PMID:
29452221
19.

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.

Schünemann HJ, Cuello C, Akl EA, Mustafa RA, Meerpohl JJ, Thayer K, Morgan RL, Gartlehner G, Kunz R, Katikireddi SV, Sterne J, Higgins JP, Guyatt G; GRADE Working Group.

J Clin Epidemiol. 2019 Jul;111:105-114. doi: 10.1016/j.jclinepi.2018.01.012. Epub 2018 Feb 9.

PMID:
29432858
20.

Two alternatives versus the standard Grading of Recommendations Assessment, Development and Evaluation (GRADE) summary of findings (SoF) tables to improve understanding in the presentation of systematic review results: a three-arm, randomised, controlled, non-inferiority trial.

Yepes-Nuñez JJ, Morgan RL, Mbuagbaw L, Carrasco-Labra A, Chang S, Hempel S, Shekelle P, Helfand M, Baldeh T, Schünemann HJ.

BMJ Open. 2018 Jan 23;8(1):e015623. doi: 10.1136/bmjopen-2016-015623.

21.

The challenge with systematic reviews of non-randomised studies in urology.

Dahm P, Jung JH, Morgan RL.

BJU Int. 2018 Feb;121(2):161-162. doi: 10.1111/bju.14105. No abstract available.

22.

Have We Not Learned from Past Mistakes?

Shah R, Morgan RL, Falck-Ytter Y, Mustafa RA.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1499-1500. doi: 10.1164/rccm.201711-2200LE. No abstract available.

PMID:
29345959
23.

Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis.

Ren CL, Morgan RL, Oermann C, Resnick HE, Brady C, Campbell A, DeNagel R, Guill M, Hoag J, Lipton A, Newton T, Peters S, Willey-Courand DB, Naureckas ET.

Ann Am Thorac Soc. 2018 Mar;15(3):271-280. doi: 10.1513/AnnalsATS.201707-539OT.

PMID:
29342367
24.

Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies.

Hooijmans CR, de Vries RBM, Ritskes-Hoitinga M, Rovers MM, Leeflang MM, IntHout J, Wever KE, Hooft L, de Beer H, Kuijpers T, Macleod MR, Sena ES, Ter Riet G, Morgan RL, Thayer KA, Rooney AA, Guyatt GH, Schünemann HJ, Langendam MW; GRADE Working Group.

PLoS One. 2018 Jan 11;13(1):e0187271. doi: 10.1371/journal.pone.0187271. eCollection 2018. Review.

25.

Effect of Point-of-Care Diagnostics on Maternal Outcomes in Human Immunodeficiency Virus-Infected Women: Systematic Review and Meta-analysis.

Mashamba-Thompson TP, Morgan RL, Sartorius B, Dennis B, Drain PK, Thabane L.

Point Care. 2017 Jun;16(2):67-77.

26.

Pseudolesions Impersonating Osseous Tumor Involvement on Both Contrast Enhanced CT and FDG PET/CT.

Peterson JK, Morgan RL, Donald JS, Perry MA.

Clin Nucl Med. 2018 Jan;43(1):68-70. doi: 10.1097/RLU.0000000000001910.

PMID:
29166329
27.

Reviewing RECIST in the Era of Prolonged and Targeted Therapy.

Morgan RL, Camidge DR.

J Thorac Oncol. 2018 Feb;13(2):154-164. doi: 10.1016/j.jtho.2017.10.015. Epub 2017 Nov 4. Review.

28.

Decision-making frameworks and considerations for informing coverage decisions for healthcare interventions: a critical interpretive synthesis.

Morgan RL, Kelley L, Guyatt GH, Johnson A, Lavis JN.

J Clin Epidemiol. 2018 Feb;94:143-150. doi: 10.1016/j.jclinepi.2017.09.023. Epub 2017 Oct 6.

PMID:
28988959
29.

What does expert opinion in guidelines mean? a meta-epidemiological study.

Ponce OJ, Alvarez-Villalobos N, Shah R, Mohammed K, Morgan RL, Sultan S, Falck-Ytter Y, Prokop LJ, Dahm P, Mustafa RA, Murad MH.

Evid Based Med. 2017 Oct;22(5):164-169. doi: 10.1136/ebmed-2017-110798. Epub 2017 Sep 18. Erratum in: BMJ Evid Based Med. 2018 Apr;23 (2):78.

PMID:
28924055
30.

Advancing Guideline Development in the United States: A Call to Action by the US GRADE Network.

Morgan RL, Sultan S, Murad MH, Mustafa RA, Dahm P, Helfand M, Falck-Ytter Y, Qaseem A.

Am J Med Qual. 2018 Mar/Apr;33(2):117-118. doi: 10.1177/1062860617726855. Epub 2017 Aug 28. No abstract available.

PMID:
28845692
31.

Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.

Zhang Y, Coello PA, Brożek J, Wiercioch W, Etxeandia-Ikobaltzeta I, Akl EA, Meerpohl JJ, Alhazzani W, Carrasco-Labra A, Morgan RL, Mustafa RA, Riva JJ, Moore A, Yepes-Nuñez JJ, Cuello-Garcia C, AlRayees Z, Manja V, Falavigna M, Neumann I, Brignardello-Petersen R, Santesso N, Rochwerg B, Darzi A, Rojas MX, Adi Y, Bollig C, Waziry R, Schünemann HJ.

Health Qual Life Outcomes. 2017 May 2;15(1):52. doi: 10.1186/s12955-017-0621-0. Review.

32.

Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.

Dahm P, Oxman AD, Djulbegovic B, Guyatt GH, Murad MH, Amato L, Parmelli E, Davoli M, Morgan RL, Mustafa RA, Sultan S, Falck-Ytter Y, Akl EA, Schünemann HJ.

J Clin Epidemiol. 2017 Jun;86:129-139. doi: 10.1016/j.jclinepi.2017.02.019. Epub 2017 Apr 1.

PMID:
28377194
33.

Engaging Senior Residents in Medical Student Education: A Resident's Perspective.

Aripoli AM, Miller KA, Fishback SJ, Morgan RL.

J Am Coll Radiol. 2017 May;14(5):678-680. doi: 10.1016/j.jacr.2016.12.012. Epub 2017 Feb 6. No abstract available.

PMID:
28185751
34.

Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient-important outcomes.

Fei Y, Guyatt GH, Alexander PE, El Dib R, Siemieniuk RAC, Vandvik PO, Nunnally ME, Gomaa H, Morgan RL, Agarwal A, Zhang Y, Bhatnagar N, Spencer FA.

J Eval Clin Pract. 2018 Feb;24(1):222-231. doi: 10.1111/jep.12663. Epub 2017 Jan 16. Review.

PMID:
28090731
35.

GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT.

Schünemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, Brignardello-Petersen R, Neumann I, Falavigna M, Alhazzani W, Santesso N, Zhang Y, Meerpohl JJ, Morgan RL, Rochwerg B, Darzi A, Rojas MX, Carrasco-Labra A, Adi Y, AlRayees Z, Riva J, Bollig C, Moore A, Yepes-Nuñez JJ, Cuello C, Waziry R, Akl EA.

J Clin Epidemiol. 2017 Jan;81:101-110. doi: 10.1016/j.jclinepi.2016.09.009. Epub 2016 Oct 3.

36.

Localization, Shedding, Regulation and Function of Aminopeptidase N/CD13 on Fibroblast like Synoviocytes.

Morgan RL, Behbahani-Nejad N, Endres J, Amin MA, Lepore NJ, Du Y, Urquhart A, Chung KC, Fox DA.

PLoS One. 2016 Sep 22;11(9):e0162008. doi: 10.1371/journal.pone.0162008. eCollection 2016.

37.

Rounding Radiologists: Clinical Collaboration Between Radiology Residents and Internal Medicine Teams.

Aripoli AM, Fishback SJ, Morgan RL, Hill JD, Robinson AL.

J Am Coll Radiol. 2016 May;13(5):562-5. doi: 10.1016/j.jacr.2015.10.027. Epub 2016 Feb 24. No abstract available.

PMID:
26922596
38.

Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage Procedures.

MacKellar DA, Williams D, Storer N, Okello V, Azih C, Drummond J, Nuwagaba-Biribonwoha H, Preko P, Morgan RL, Dlamini M, Byrd J, Agolory S, Baughman AL, McNairy ML, Sahabo R, Ehrenkranz P.

PLoS One. 2016 Feb 24;11(2):e0150086. doi: 10.1371/journal.pone.0150086. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0152108.

39.

How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards.

Rooney AA, Cooper GS, Jahnke GD, Lam J, Morgan RL, Boyles AL, Ratcliffe JM, Kraft AD, Schünemann HJ, Schwingl P, Walker TD, Thayer KA, Lunn RM.

Environ Int. 2016 Jul-Aug;92-93:617-29. doi: 10.1016/j.envint.2016.01.005. Epub 2016 Feb 6.

40.

GRADE: Assessing the quality of evidence in environmental and occupational health.

Morgan RL, Thayer KA, Bero L, Bruce N, Falck-Ytter Y, Ghersi D, Guyatt G, Hooijmans C, Langendam M, Mandrioli D, Mustafa RA, Rehfuess EA, Rooney AA, Shea B, Silbergeld EK, Sutton P, Wolfe MS, Woodruff TJ, Verbeek JH, Holloway AC, Santesso N, Schünemann HJ.

Environ Int. 2016 Jul-Aug;92-93:611-6. doi: 10.1016/j.envint.2016.01.004. Epub 2016 Jan 27.

41.

National Guidelines for Colorectal Cancer Screening in Saudi Arabia with strength of recommendations and quality of evidence.

Alsanea N, Almadi MA, Abduljabbar AS, Alhomoud S, Alshaban TA, Alsuhaibani A, Alzahrani A, Batwa F, Hassan AH, Hibbert D, Nooh R, Alothman M, Rochwerg B, Alhazzani W, Morgan RL.

Ann Saudi Med. 2015 May-Jun;35(3):189-95. doi: 10.5144/0256-4947.2015.189. Review.

42.

HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care.

Yartel AK, Morgan RL, Rein DB, Ann Brown K, Kil NB, Massoud OI, Fallon MB, Smith BD.

Am J Prev Med. 2015 Sep;49(3):423-7. doi: 10.1016/j.amepre.2015.03.003. Epub 2015 Apr 18.

43.

Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.

Aspinall EJ, Doyle JS, Corson S, Hellard ME, Hunt D, Goldberg D, Nguyen T, Falck-Ytter Y, Morgan RL, Smith B, Stoove M, Wiktor SZ, Hutchinson S.

Eur J Epidemiol. 2015 Feb;30(2):115-29. doi: 10.1007/s10654-014-9958-4. Epub 2014 Nov 11. Review.

44.

How much management is necessary? Sustaining the benefit of achieving a sustained virologic response to hepatitis C.

Morgan RL.

J Gastroenterol. 2014 Nov;49(11):1514-5. doi: 10.1007/s00535-014-0990-7. Epub 2014 Sep 20. No abstract available.

PMID:
25239674
45.

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ.

Genet Med. 2015 Jan;17(1):63-7. doi: 10.1038/gim.2014.69. Epub 2014 Jun 19.

46.

Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies.

Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y.

Ann Intern Med. 2013 Mar 5;158(5 Pt 1):329-37. doi: 10.7326/0003-4819-158-5-201303050-00005. Review.

PMID:
23460056
47.

Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.

Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW.

Ann Intern Med. 2012 Dec 4;157(11):817-22.

48.

Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW; Centers for Disease Control and Prevention.

MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32. Erratum in: MMWR Recomm Rep. 2012 Nov 2;61(43):886.

49.

Lateral knee pain in a male college student.

Kujawski EJ, Morgan RL.

Am Fam Physician. 2012 Mar 1;85(5):509-10. No abstract available.

50.

Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function.

Frazier DP, Kendig RD, Kai F, Maglic D, Sugiyama T, Morgan RL, Fry EA, Lagedrost SJ, Sui G, Inoue K.

Cancer Res. 2012 Apr 1;72(7):1740-50. doi: 10.1158/0008-5472.CAN-11-2410. Epub 2012 Feb 13.

Supplemental Content

Loading ...
Support Center